Bifidobacterium lactis combined with Lactobacillus plantarum inhibit glioma growth in mice through modulating PI3K/AKT pathway and gut microbiota

Abstract

Glioma is a common primary aggressive tumor with limited clinical treatment. Recently, growing research suggests that gut microbiota is involved in tumor progression, and several probiotics can inhibit tumor growth. However, evidence for the effect of probiotics on glioma is lacking. Here, we found that Bifidobacterium (B.) lactis combined with Lactobacillus (L.) plantarum reduced tumor volume, prolonged survival time and repaired the intestinal barrier damage in an orthotopic mouse model of glioma. Experiments demonstrated that B. lactis combined with L. plantarum suppressed the PI3K/AKT pathway and down-regulated the expression of Ki-67 and N-cadherin. The glioma-inhibitory effect of probiotic combination is also related to the modulation of gut microbiota composition, which is characterized by an increase in relative abundance of Lactobacillus and a decrease in some potential pathogenic bacteria. Additionally, probiotic combination altered fecal metabolites represented by fatty acyls and organic oxygen compounds. Together, our results prove that B. lactis combined with L. plantarum can inhibit glioma growth by suppressing PI3K/AKT pathway and regulating gut microbiota composition and metabolites in mice, thus suggesting the potential benefits of B. lactis and L. plantarum against glioma.

SKA2-mediated transcriptional downregulation of the key enzyme of CoQ10 biosynthesis PDSS2 in lung cancer cells

“…Although little evidence exists for Bifidobacterium improving survival in CRC patients, the existing literature and our results suggest that Bifidobacterium is a potential diagnostic and prognostic marker for CRC. Recently, it has been reported that Bifidobacterium lactis and Lactobacillus plantarum suppress glioma growth in mice by inhibiting the PI3K-Akt pathway [103]. Our results revealed that the AA pathway was lower but the KEGG enrichment analysis of the 14 upregulatedhypomethylated genes was associated with mTOR signaling pathway in the high-BMI CRC patients.…”

Bioinformatic analysis of the obesity paradox and possible associated factors in colorectal cancer using TCGA cohorts

“…Although little evidence exists for Bifidobacterium improving survival in CRC patients, the existing literature and our results suggest that Bifidobacterium is a potential diagnostic and prognostic marker for CRC. Recently, it has been reported that Bifidobacterium lactis and Lactobacillus plantarum suppress glioma growth in mice by inhibiting the PI3K-Akt pathway 103 . Our results revealed that the AA pathway was lower but the KEGG enrichment analysis of the 14 upregulated-hypomethylated genes was associated with mTOR signaling pathway in the high-BMI CRC patients.…”

Radioprotective potential of probiotics against gastrointestinal and neuronal toxicity: a preclinical study

“…Further, probiotics have been found to decrease cancer, particularly glioma, which accounts for 81% of all the malignant tumors of the central nervous system and is the most prevalent kind. Wang et al demonstrated that B. lactis and L. plantarum could suppress the growth of gliomas in mice by changing the structure and metabolites of their gut microbiota and blocking the PI3K/AKT pathway [50].…”